Your Cart Item
Reports Within

Parameters

Reports Within:

Parameter Include:

Requisites
Measures

Number of red blood cells in the blood

Identifies

Red blood cell disorders

Measures: Number of red blood cells in the blood

Identifies: Red blood cell disorders

60
Mins

Homes

1M
Happy

Customers

4.9
Google

Rating

Certified

Labs

What is the maximum days the report can be obtained for the test

The maximum days for obtaining the report for the test BCR/ABL Qualitative (Philadelphia Chromosome) Test is typically 7-10 business days.

What are the prerequisites for the test BCR/ABL Qualitative (Philadelphia Chromosome) Test

  1. There are no specific prerequisites for the BCR/ABL Qualitative Test. However, it is often ordered for patients suspected to have chronic myelogenous leukemia (CML) or acute lymphoblastic leukemia (ALL) with the Philadelphia chromosome.
  2. Prior to the test, a healthcare provider may take a medical history, perform a physical examination, and order other tests to determine the need for the BCR/ABL test.
  3. It is important to inform the healthcare provider about any medications, supplements, or medical conditions that may interfere with the test results.
  4. Patients may be asked to fast for a few hours before the test, but this is not always necessary.
  5. It is recommended to follow any instructions provided by the healthcare provider or laboratory performing the test.

What are the measure values for the test BCR/ABL Qualitative (Philadelphia Chromosome) Test

  • Positive: BCR/ABL fusion gene detected
  • Negative: BCR/ABL fusion gene not detected

What does this test BCR/ABL Qualitative (Philadelphia Chromosome) Test identify?

The BCR/ABL Qualitative (Philadelphia Chromosome) Test identifies the presence of the BCR/ABL fusion gene, which is associated with a specific type of leukemia known as chronic myeloid leukemia (CML). This test is used to confirm the diagnosis of CML and to monitor treatment response in patients with this type of leukemia.

Why is this test BCR/ABL Qualitative (Philadelphia Chromosome) Test taken?

Why is the BCR/ABL Qualitative (Philadelphia Chromosome) Test taken?

The BCR/ABL Qualitative Test is taken to detect the presence of the Philadelphia chromosome, which is a specific genetic abnormality commonly found in individuals with chronic myeloid leukemia (CML) and a subset of acute lymphoblastic leukemia (ALL).

By identifying the BCR/ABL fusion gene, this test helps in diagnosing CML and monitoring the response to treatment. It is also used to confirm the presence of the Philadelphia chromosome in individuals suspected of having CML or ALL.

Overall, the BCR/ABL Qualitative Test is crucial for the accurate diagnosis and management of leukemia, as well as for determining the appropriate treatment options for affected individuals.

No FAQs available.

Customer Google Rating